3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Radiation Injuries
1
Neurotoxicity Syndromes
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Interventions
Fluorouracil
17
Cisplatin
17
pembrolizumab
12
Radiotherapy
11
Oxaliplatin
10
Irinotecan
9
Paclitaxel
6
Leucovorin
6
Docetaxel
6
Carboplatin
6
Capecitabine
6
Neoadjuvant Therapy
5
Trastuzumab
4
Panitumumab
4
Gefitinib
4
Esophagectomy
4
Cyclophosphamide
4
Cetuximab
4
Surgical Procedures, Operative
3
Celecoxib
3
tegafur-gimeracil-oteracil
2
spartalizumab
2
sodium glycididazole
2
niraparib
2
fludarabine
2
S 1 (combination)
2
Plicamycin
2
Pemetrexed
2
Lapatinib
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Esophageal Neoplasms
×
Lithium
×
Clear all
NCT03153280
2025-07-08
Lithium
Cancer Trials Ireland
Phase 1
Terminated
2 enrolled